Liraglutide, sold under the brand name Victoza, is a medication used to treat diabetes mellitus type 2 and obesity. Liraglutide causes a glucose-dependent increase in insulin secretion, decreases glucagon secretion and promotes weight loss by inhibiting appetite.
Vitrakvi is a TRK inhibitor that works against cancers anywhere in the body with NTRK gene fusions. It is the first cancer drug which to be designed from the start to fight a specific genetic mutation, not a traditional cancer type.
Researchers in England say they have the first evidence that a drug named dexamethasone can improve COVID-19 survival: A cheap and widely used steroid can reduce the deaths by up to one third in severely ill hospitalized patients.